Harnessing the Endogenous Melanocortin System to Resolve IBD – A New Paradigm to Treat Inflammatory Diseases

Time: 9:00 am
day: Conference Day Two


  • Biasing tissue and immune cells towards resolving inflammation
  • Unprecedented safety by employing the natural mode of resolution removes efficacy/ toxicity balance considerations
  • Exploring the need for and type of patient stratification biomarkers